NCT06921837
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06921837
Title A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bolt Biotherapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
AUS Site 2 RECRUITING Darlinghurst New South Wales Australia Details
AUS Site 5 RECRUITING Westmead New South Wales Australia Details
AUS Site 1 RECRUITING Birtinya Queensland Australia Details
AUS Site 4 RECRUITING Clayton Victoria Australia Details
AUS Site 3 RECRUITING Heidelberg Victoria Australia Details
SK Site 2003 RECRUITING Seongnam-si South Korea Details
SK Site 2001 RECRUITING Seoul South Korea Details
SK Site 2002 RECRUITING Seoul South Korea Details
SK Site 2004 RECRUITING Seoul South Korea Details
SK Site 2005 RECRUITING Seoul South Korea Details
TWN Site 9004 RECRUITING Kaohsiung City Taiwan Details
TWN Site 9005 RECRUITING Kaohsiung City Taiwan Details
TWN Site 9001 RECRUITING Taichung Taiwan Details
TWN Site 9003 RECRUITING Taipei Taiwan Details
TWN Site 9006 NOT_YET_RECRUITING Taipei Taiwan Details
TWN Site 9002 RECRUITING Taoyuan District Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field